Pfizer plans to test a third dose of its COVID vaccine on infants and young children

Pfizer and BioNTech, which produced the first COVID-19 vaccine authorized in the U.S., say they will expand ongoing trials to include a third dose for children as young as 6 months old.

(Image credit: Nam Y. Huh/AP)